FBTAX
Price
$26.88
Change
+$0.12 (+0.45%)
Updated
Jul 3 closing price
Net Assets
1.3B
RYCFX
Price
$40.91
Change
+$0.11 (+0.27%)
Updated
Jul 3 closing price
Net Assets
84.95M
Interact to see
Advertisement

FBTAX vs RYCFX

Header iconFBTAX vs RYCFX Comparison
Open Charts FBTAX vs RYCFXBanner chart's image
Fidelity Advisor Biotechnology A
Price$26.88
Change+$0.12 (+0.45%)
VolumeN/A
Net Assets1.3B
Rydex Biotechnology C
Price$40.91
Change+$0.11 (+0.27%)
VolumeN/A
Net Assets84.95M
FBTAX vs RYCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. RYCFX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and RYCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.3B vs. RYCFX (84.9M). FBTAX pays higher dividends than RYCFX: FBTAX (2.95) vs RYCFX (0.00). FBTAX was incepted earlier than RYCFX: FBTAX (25 years) vs RYCFX (24 years). RYCFX (2.43) is less costly to investors than FBTAX (0.96). FBTAX is a more actively managed with annual turnover of: 73.00 vs. RYCFX (51.00). FBTAX has a lower initial minimum investment than RYCFX: FBTAX (0) vs RYCFX (2500). FBTAX annual gain was more profitable for investors over the last year : -5.68 vs. RYCFX (-19.33). FBTAX return over 5 years is better than : -13.75 vs. RYCFX (-43.62).
FBTAXRYCFXFBTAX / RYCFX
Total Expense Ratio0.962.4040%
Annual Report Gross Expense Ratio0.962.4340%
Fund Existence25 years24 years-
Gain YTD-1.2130.739-164%
Front Load6%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B84.9M1,527%
Annual Yield % from dividends2.950.00-
Returns for 1 year-5.68-19.3329%
Returns for 3 years28.75-12.47-230%
Returns for 5 years-13.75-43.6232%
Returns for 10 years-8.19-53.0715%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUFEX57.580.57
+1.00%
Buffalo Blue Chip Growth
GSWPX23.790.22
+0.93%
Goldman Sachs Small/Mid Cap Growth P
BGRIX93.370.62
+0.67%
Baron Growth Instl
WHGOX12.250.04
+0.33%
Westwood Income Opportunity Ultra
DURCX13.96-0.06
-0.43%
DWS ESG International Core Eq C